000			01926 a2200553 4500
005			20250513235331.0
264		0	_c20010510
008			200105s 0 0 eng d
022			_a0950-9232
024	7		_a10.1038/sj.onc.1204196 _2doi
040			_aNLM _beng _cNLM
100	1		_aRudolph, B
245	0	0	_aExpression of Mad1 in T cells leads to reduced thymic cellularity and impaired mitogen-induced proliferation. _h[electronic resource]
260			_bOncogene _cMar 2001
300			_a1164-75 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntigens, CD _xphysiology
650	0	4	_aBlotting, Western
650	0	4	_aCell Cycle Proteins
650	0	4	_aDNA Primers _xchemistry
650	0	4	_aFemale
650	0	4	_aGenes, myc _xphysiology
650	0	4	_aH-Y Antigen _ximmunology
650	0	4	_aHistocompatibility Antigens Class I _ximmunology
650	0	4	_aImmunoenzyme Techniques
650	0	4	_aLymphocyte Activation _xdrug effects
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aMice, Inbred CBA
650	0	4	_aMice, Transgenic
650	0	4	_aMitogens _xpharmacology
650	0	4	_aNuclear Proteins
650	0	4	_aPhosphoproteins _xbiosynthesis
650	0	4	_aReceptors, Antigen, T-Cell _xgenetics
650	0	4	_aRepressor Proteins _xbiosynthesis
650	0	4	_aResting Phase, Cell Cycle _xdrug effects
650	0	4	_aReverse Transcriptase Polymerase Chain Reaction
650	0	4	_aS Phase _xdrug effects
650	0	4	_aSpleen _ximmunology
650	0	4	_aT-Lymphocytes _ximmunology
650	0	4	_aThymus Gland _ximmunology
650	0	4	_aTumor Suppressor Protein p53 _xmetabolism
700	1		_aHueber, A O
700	1		_aEvan, G I
773	0		_tOncogene _gvol. 20 _gno. 10 _gp. 1164-75
856	4	0	_uhttps://doi.org/10.1038/sj.onc.1204196 _zAvailable from publisher's website
999			_c11248266 _d11248266